Compare MLTX & GLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MLTX | GLP |
|---|---|---|
| Founded | 2021 | 2005 |
| Country | Switzerland | United States |
| Employees | N/A | 4700 |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil Refining/Marketing |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 2020 | N/A |
| Metric | MLTX | GLP |
|---|---|---|
| Price | $19.93 | $48.03 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 1 |
| Target Price | $27.50 | ★ $46.00 |
| AVG Volume (30 Days) | ★ 1.4M | 136.6K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 6.40% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $64.13 |
| Revenue Next Year | N/A | $11.74 |
| P/E Ratio | ★ N/A | $23.28 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.95 | $39.58 |
| 52 Week High | $62.75 | $53.25 |
| Indicator | MLTX | GLP |
|---|---|---|
| Relative Strength Index (RSI) | 55.88 | 55.82 |
| Support Level | $15.54 | $45.18 |
| Resistance Level | $21.00 | $50.58 |
| Average True Range (ATR) | 1.06 | 1.78 |
| MACD | -0.11 | 0.46 |
| Stochastic Oscillator | 27.74 | 88.75 |
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.
Global Partners LP is a limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the GDSO segment.